Pharmaceutical Technology

APRIL 24, 2023

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

Vaccines 59

Vaccines Immunity Immunization Medical Schools 59

Pharmacy Joe

FEBRUARY 24, 2021

In this episode, I’ll discuss the CDC Recommendations if a patient develops COVID-19 before receiving the 2nd vaccine dose. Patients who get COVID-19 before their 2nd vaccine dose and are treated with a monoclonal antibody, and 2. This guidance also applies to people who get COVID-19 before getting their second dose of vaccine.

Vaccines 40

Vaccines Inpatient Immunity Immunization 40

Pharmaceutical Technology

MARCH 24, 2023

Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.

Vaccines 64

Vaccines Health and Personal Care Stores Immunity Immunization 64

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?

Vaccines 52

Vaccines Nursing Homes Communication Pharmaceutical Companies 52

Digital Pharmacist

OCTOBER 25, 2023

You can even download additional resources and graphics related to national diabetes day at this link. Promote Routine Immunizations People with diabetes are at a higher risk of complications from infections.

Diabetes 105

Diabetes Medication Therapy Management (MTM) Immunity Immunization 105

Express Pharma

JUNE 12, 2024

Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. Big pharma companies are engaging in divestitures to accumulate prolific dry powder from freed-up capital permitting investment in their core focus areas.

Generic Medicine 105

Generic Medicine Vaccines Diabetes Immunity 105

Express Pharma

JUNE 21, 2024

Covid-19 promoted India to the centre stage of global vaccines export as consumerisation of health providing an impetus for vaccines and prompt approvals. Big pharma companies are engaging in divestitures to accumulate prolific dry powder from freed up capital permitting investment in their core focus areas.

Generic Medicine 102

Generic Medicine Vaccines Diabetes Immunity 102

Digital Pharmacist

JANUARY 16, 2023

World Immunization Week: April 24-30. National Immunization Awareness Month. National Influenza Vaccination Week: December 6-12. Cervical Health Awareness Month | S hare downloadable content from the NCCC and advocate for HPV vaccinations. National Cancer Prevention Month. National Kidney Month. UV Safety Month.

Immunity 98

Immunity Immunization Vaccines Diabetes 98

Pharmacy Joe

JUNE 12, 2024

This could become of clinical significance in the administration of vaccines, benzodiazepines, and antipsychotics. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. According to this formula, A 1-inch needle is expected to reach the deltoid in 85.3%

Inpatient 52

Inpatient Immunity Immunization Vaccines 52

Quality Matters

JUNE 17, 2024

Types of biologics include hormone therapies, transplant tissues, monoclonal antibodies, vaccines and cell and gene therapies. They can also help stimulate the body’s immune system to attack disease-causing cells or organisms. How do biologics work? Different kinds of biologics exert their therapeutic effects in different ways.

Biosimilars 52

Biosimilars Dosage Immunity Immunization 52

Pharmaceutical Technology

MARCH 21, 2023

Source: GlobalData Pharmaceutical Intelligence Center Clinical trial catalysts In late January, AC Immune released positive interim results from the Phase I/II trial (NCT05462106) studying the company’s vaccine in patients with prodromal Alzheimer’s disease. Please check your email to download the Report.

Packaging 59

Packaging Vaccines Labelling Communication 59

FADIC

JANUARY 22, 2023

A Comprehensive Guide Antibiotic Safety Antibiotics aren’t routinely prescribed for mild bacterial infections as they can be resolved by the immune system. Additionally, it’s better to follow personal hygiene and administer vaccines to avoid the spread of infection and unnecessary use of antibiotics.

Dosage 52

Dosage Packaging Immunity Immunization 52

Pharmaceutical Technology

DECEMBER 1, 2022

A clinical-stage biopharmaceutical firm, Liminatus focuses on the development of new therapies for cancer that utilises the immune system of the body to detect and fight cancer cells. The GCC Vaccine is being analysed in Phase II clinical trials. The boards of directors of both companies have granted approval for the merger.

Immunization 52

Immunization Immunity Vaccines Communication 52

Pharmacy Joe

FEBRUARY 27, 2022

This could become of clinical significance in the administration of vaccines, benzodiazepines, and antipsychotics. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. According to this formula, A 1-inch needle is expected to reach the deltoid in 85.3%

Inpatient 40

Inpatient Immunity Immunization Vaccines 40

pharmaphorum

AUGUST 16, 2022

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. . Download the full event guide to find out more.

Clinical Pharmacology 52

Clinical Pharmacology Immunization Immunity Vaccines 52

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. The approval of the mRNA Covid-19 vaccine, which is a biologic, has thrust the modality even further into the spotlight.

Vaccines 52

Vaccines Compounding Communication Immunity 52

Pharmaceutical Technology

DECEMBER 5, 2022

With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub. With an initial focus on enchaining mRNA technology and developing a vaccine for Chlamydia, the research at the hub is anticipated to commence in the first quarter of next year.

Vaccines 98

Vaccines Communication Immunity Immunization 98

Pharmaceutical Technology

JUNE 8, 2023

The partnership’s initial focus is to support drug developers to advance cell and gene therapies (CGT) using pioneering modalities including viral vectors (AAV, LVV, RV and HSV), antibodies (mAb, bsAb and ADC), CAR-T therapies and vaccines (DNA, mRNA and protein).

Vaccines 52

Vaccines Drug Development Immunity Immunization 52

Pharmaceutical Technology

MAY 24, 2023

Morphogenesis’s technologies include Immune Fx (IFx) personalised cancer vaccines and tumour microenvironment (TME) modulators. IFx has been designed to activate an innate immune response against tumour antigens that are patient-specific. Morphogenesis’ lead personalised cancer vaccine, IFx-Hu2.0,

Immunity 52

Immunity Immunization Vaccines 52

pharmaphorum

MARCH 23, 2021

In the fight against emerging coronavirus variants and spike mutations, the need for long-lasting immunity is greater than ever. This is why the time is now to look beyond antibodies and capitalize on the long-term immune response of T cell therapies. Download the event guide here. Gavin MacBeath, CSO, TScan Therapeutics.

Immunity 52

Immunity Immunization Vaccines 52

Pharmaceutical Technology

FEBRUARY 24, 2023

On December 20, 2022, the World Health Organization (WHO) updated its recommendations for cervical cancer vaccines in a bid to boost vaccination coverage. Several cervical cancer vaccines are currently approved, including Merck’s nonavalent vaccine Gardasil 9 and GSK’s bivalent vaccine Cervarix.

Vaccines 116

Vaccines Communication Medical Schools Immunity 116

Pharmacy Joe

FEBRUARY 13, 2022

In this episode, I’ll discuss when rabies immune globulin is indicated. Episode 687: How to decide when to give rabies immune globulin? Subscribe on iTunes , Android , or Stitcher Rabies immune globulin (RIG) administration is part of successful rabies post-exposure prophylaxis. The dose of RIG is 20 units/kg x 1.

Immunity 40

Immunity Immunization Vaccines Inpatient 40

European Pharmaceutical Review

JUNE 28, 2024

The post <em>European Pharmaceutical Review </em> Issue 3 2024 appeared first on European Pharmaceutical Review.

Research Laboratories 52

Research Laboratories Vaccines Drug Development Immunity 52

Eye on FDA

MARCH 31, 2021

This week New York became the first state to make available a means for mobile digital confirmation that an individual has been vaccinated for COVID-19. Popularly known as “immunity passports” they are in fact more than that. When you download the app, you will be directed to provide information to confirm your identity.

Vaccines 98

Vaccines Immunity Immunization Hospitals 98

Pharmaceutical Technology

FEBRUARY 20, 2023

The capabilities of Viroclinics and DDL allowed us to rapidly test repurposed drugs, new vaccines and antiviral solutions for the prevention and treatment of patients affected by COVID-19 in 2020. Please check your email to download the Whitepaper. What future developments are you most excited about being part of Cerba Research?

Vaccines 52

Vaccines Communication Immunity Immunization 52

Pharmacy Friday Pearls

MARCH 4, 2022

Download PDF. 1 risk factor for progression to severe disease a No prior COVID-19 vaccine or infectionStandard of care treatment allowed but primary analysis population was limited to subjects who did NOT receive COVID-19 monoclonal antibodies COVID-19 related hospitalizations/death through day 28: 0.8% Author: Alyssa Lear, PharmD.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunity 40

RX Note

FEBRUARY 23, 2023

- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58